Chief Medical Officer and Head of Research and Development of Voyager Therapeutics. Previously Global Head of Neuroscience Translational Medicine and Rare Diseases at Roche, and before that Chief Resident at Harvard Medical School. MD Ph.D. from the University of Cambridge, UK.
Current role